iDrugBank

Clinical Trials, Phase I as Topic

MESHD017321

Works about studies performed to evaluate the safety of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques in healthy subjects and to determine the safe dosage range (if appropriate). These tests also are used to determine pharmacologic and pharmacokinetic properties (toxicity, metabolism, absorption, elimination, and preferred route of administration). They involve a small number of persons and usually last about 1 year. This concept includes phase I studies conducted both in the U.S. and in other countries.

Synonyms

  • Phase I Clinical Trial
  • Phase 1 Clinical Trial
  • Clinical Trials, Phase I
  • Clinical Trials, Phase 1
  • Phase 1 Clinical Trials
  • Phase I Clinical Trials
  • Drug Evaluation, FDA Phase I as Topic
  • Drug Evaluation, FDA Phase I
  • Drug Evaluation, FDA Phase 1
  • Evaluation Studies, FDA Phase I
  • Evaluation Studies, FDA Phase 1
  • Microdosing Trials, Human
  • Human Microdosing Trial
  • Microdosing Trial, Human
  • Trial, Human Microdosing
  • Trials, Human Microdosing
  • Human Microdosing Trials

Source last updated 2026-05-24T15:25:55.068Z